Judge Clears Boston Scientific In $200M Stent Patent Case
A California federal judge has found that Boston Scientific Corp. did not infringe a stent patent asserted against it by cardiologist David Jang, who claimed that the company owed him more...To view the full article, register now.
Already a subscriber? Click here to view full article